Alivernini, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 2.661
EU - Europa 2.335
AS - Asia 984
AF - Africa 20
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 6.018
Nazione #
US - Stati Uniti d'America 2.635
IT - Italia 508
SE - Svezia 420
CN - Cina 396
PL - Polonia 376
SG - Singapore 311
DE - Germania 277
FR - Francia 204
IE - Irlanda 159
UA - Ucraina 93
ID - Indonesia 91
GB - Regno Unito 75
IN - India 70
FI - Finlandia 64
RU - Federazione Russa 43
TR - Turchia 30
BE - Belgio 28
HK - Hong Kong 24
CA - Canada 22
JP - Giappone 16
NL - Olanda 15
CI - Costa d'Avorio 13
IR - Iran 13
VN - Vietnam 12
CH - Svizzera 9
ES - Italia 9
GR - Grecia 7
RO - Romania 7
LT - Lituania 6
CZ - Repubblica Ceca 5
IL - Israele 5
MD - Moldavia 5
ZA - Sudafrica 5
AT - Austria 4
CL - Cile 4
MX - Messico 4
MY - Malesia 4
AR - Argentina 3
AU - Australia 3
DK - Danimarca 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
EE - Estonia 2
EU - Europa 2
KR - Corea 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
IQ - Iraq 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 6.018
Città #
Chandler 508
Warsaw 365
Ashburn 249
Singapore 238
Fairfield 168
Dublin 142
Rome 130
Wilmington 115
Dearborn 104
New York 102
Woodbridge 98
Ann Arbor 96
Seattle 91
Jakarta 90
Houston 75
Nanjing 72
Milan 69
Cambridge 68
Cattolica 62
Jacksonville 54
San Mateo 53
Princeton 50
Beijing 47
Boston 47
Bremen 44
Chicago 37
Marseille 35
Helsinki 32
Moscow 29
Redwood City 28
Izmir 24
Brussels 23
Pune 23
Redmond 22
Hong Kong 21
Boardman 19
Lawrence 19
Nanchang 19
London 18
Kunming 16
Los Angeles 16
Munich 16
Norwalk 15
Shenyang 15
Hangzhou 14
Tianjin 14
Abidjan 13
Toronto 13
Lancaster 12
Andover 11
Dong Ket 10
Guangzhou 10
Hebei 10
Lappeenranta 10
Mountain View 10
Santa Maria 10
Washington 10
Busto Arsizio 9
San Diego 9
Tokyo 9
Falkenstein 8
Fuzhou 8
Paris 8
Augusta 7
Jiaxing 7
Jinan 7
Leawood 7
Nürnberg 7
Strasbourg 7
Zurich 7
Dijon 6
Falls Church 6
Parma 6
Phoenix 6
San Vito Chietino 6
Amsterdam 5
Brno 5
Catania 5
Frankfurt am Main 5
Herenthout 5
Kraków 5
Shanghai 5
University Park 5
Vancouver 5
Athens 4
Boydton 4
Edinburgh 4
Fremont 4
Muizenberg 4
Naples 4
Nuremberg 4
Renton 4
Senigallia 4
Tiraspol 4
Wuhan 4
Zhengzhou 4
Ashfield 3
Changchun 3
Changsha 3
Chengdu 3
Totale 3.946
Nome #
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 299
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 273
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 261
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 207
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 194
Synovial tissue macrophages: friend or foe? 152
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 139
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 138
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 135
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 122
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 114
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 102
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 99
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 94
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 91
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 91
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 89
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 89
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 88
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 87
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 87
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 85
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 84
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 83
Postural control and disability in patients with early rheumatoid arthritis 82
Sarilumab use in severe SARS-CoV-2 pneumonia 80
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 77
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 73
Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission 71
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 70
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 70
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 70
The pathogenesis of rheumatoid arthritis 68
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 68
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 68
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 67
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 67
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 65
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 65
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 64
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 64
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 59
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 58
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 57
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 56
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 56
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 56
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 55
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs 54
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 54
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 53
The B side of rheumatoid arthritis pathogenesis 53
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 51
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 50
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 50
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 47
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 46
Malnutrition in COVID-19 survivors: prevalence and risk factors 45
Telemedicine will not keep us apart in COVID-19 pandemic 45
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 43
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 40
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 40
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection 40
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 38
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 38
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 37
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 34
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 30
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 30
COVID-19 atypical Parsonage-Turner syndrome: a case report 29
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 29
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48 29
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 28
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 28
Malnutrition in COVID-19 survivors: prevalence and risk factors 27
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 27
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations 25
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution 23
Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis 22
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 21
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 19
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 18
Bispecific T cell engager therapy for refractory rheumatoid arthritis 16
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials 16
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 15
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 15
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 14
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 14
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 10
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 8
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 8
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 5
Totale 6.153
Categoria #
all - tutte 32.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020353 0 0 0 0 0 0 75 51 63 45 80 39
2020/2021568 59 43 26 34 75 38 49 11 73 63 72 25
2021/2022719 95 46 32 52 45 18 15 74 44 51 97 150
2022/20231.525 177 184 114 231 115 187 65 121 191 62 51 27
2023/20241.056 42 219 50 52 43 189 96 37 39 70 141 78
2024/2025556 36 38 152 97 149 83 1 0 0 0 0 0
Totale 6.153